Functional impairment in patients with major depressive disorder: the 2-year PERFORM study
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Prospective Epidemiological Research on Functioning Outcomes Related to Major depressive disorder (PERFORM) study describes the course of depressive symptoms, perceived cognitive symptoms, and functional impairment over 2 years in outpatients with major depressive disorder (MDD) and investigates the patient-related factors associated with functional impairment. METHODS: This was a 2-year observational study in 1,159 outpatients with MDD aged 18-65 years who were either initiating antidepressant monotherapy or undergoing their first switch of antidepressant. Functional impairment was assessed by the Sheehan Disability Scale and the Work Productivity and Activity Impairment questionnaire. Patients assessed depression severity using the nine-item Patient Health Questionnaire and severity of perceived cognitive symptoms using the five-item Perceived Deficit Questionnaire. To investigate which patient-related factors were associated with functional impairment, univariate analyses of variance were performed to identify relevant factors that were then included in multivariate analyses of covariance at baseline, month 2, months 6 and 12 combined, and months 18 and 24 combined. RESULTS: The greatest improvement in depressive symptoms, perceived cognitive symptoms, and functional impairment was seen immediately (within 2 months) following initiation or switch of antidepressant therapy, followed by more gradual improvement and long-term stabilization. Improvement in perceived cognitive symptoms was less marked than improvement in depressive symptoms during the acute treatment phase. Functional impairment in patients with MDD was not only associated with severity of depressive symptoms but also independently associated with severity of perceived cognitive symptoms when adjusted for depression severity throughout the 2 years of follow-up. CONCLUSION: These findings highlight the burden of functional impairment in MDD and the importance of recognizing and managing cognitive symptoms in daily practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754 · cited 1×
“9% of the total population in this age group – experience depression during a 12-month period.(2) Compared with the general population, patients with MDD report substantial functional impairment.”
Self-citationSheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Cost of Lost Productive Work Time Among US Workers With Depression
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.289.23.3135 · Cited by 1,421
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
McIntyre, R. S., Cha, D. S., Soczynska, J. K., Woldeyohannes, H. O., Gallaugher, L. A., Kudlow, P., Alsuwaidan, M., & Baskaran, A. (2013) · Depression and Anxiety · doi:10.1002/da.22063 · Cited by 765
Job Performance Deficits Due to Depression
Adler, D. A., McLaughlin, T. J., Rogers, W. H., Chang, H., Lapitsky, L., & Lerner, D. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1569 · Cited by 531
Conradi, H. J., Ormel, J., & de Jonge, P. (2011) · Psychological Medicine · doi:10.1017/s0033291710001911 · Cited by 515
Neurocognitive deficits and disability in major depressive disorder
Jaeger, J., Berns, S., Uzelac, S., & Davis-Conway, S. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.11.011 · Cited by 484
How Should Remission From Depression Be Defined? The Depressed Patient’s Perspective
Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, N., & Boerescu, D. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.148 · Cited by 431 · cited 1×
“From a patient’s perspective, return to usual levels of functioning may be as important a treatment outcome as resolution of depressive symptoms.(22,23)”
Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review
Hasselbalch, B. J., Knorr, U., & Kessing, L. V. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.11.011 · Cited by 406 · cited 1×
“Other studies have shown that cognitive symptoms persist longer than depressive symptoms in patients with MDD and that these residual cognitive symptoms can persist even in patients who achieve clinical remission.(37,38) Furthermore, in a previous analysis, residual perceived cognitive symptoms in patients who achieve…”
McKnight, P. E., & Kashdan, T. B. (2009) · Clinical Psychology Review · doi:10.1016/j.cpr.2009.01.005 · Cited by 400
Evans-Lacko, S., & Knapp, M. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1278-4 · Cited by 390 · cited 1×
“51 The only other factor found to be significantly associated with all functional outcomes was country at the baseline visit.”
Birnbaum, H. G., Kessler, R. C., Kelley, D., Ben-Hamadi, R., Joish, V. N., & Greenberg, P. E. (2010) · Depression and Anxiety · doi:10.1002/da.20580 · Cited by 380
Hirschfeld, R. M. A., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., Markowitz, J. C., Miller, I., Nemeroff, C. B., Ninan, P. T., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01291-4 · Cited by 231
Defining and Measuring Functional Recovery from Depression
Greer, T. L., Kurian, B. T., & Trivedi, M. H. (2010) · CNS Drugs · doi:10.2165/11530230-000000000-00000 · Cited by 222
Woo, Y. S., Rosenblat, J. D., Kakar, R., Bahk, W.-M., & McIntyre, R. S. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.1.1 · Cited by 183 · cited 4×
“This finding is consistent with previous data showing that cognitive symptoms have a major impact on functional recovery in MDD. 45,46 Residual cognitive symptoms have also been shown to be a principal mediator of occupational impairment in patients with remitted MDD. 47,48 In our study, perceived cognitive symptoms w…”
InfluentialCognitive dysfunction in major depressive disorder: a state-of-the-art clinical review
Bortolato, B., Carvalho, A., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203823 · Cited by 181 · cited 4×
“This finding is consistent with previous data showing that cognitive symptoms have a major impact on functional recovery in MDD. 45,46 Residual cognitive symptoms have also been shown to be a principal mediator of occupational impairment in patients with remitted MDD. 47,48 In our study, perceived cognitive symptoms w…”
InfluentialNaismith, S. L., Longley, W. A., Scott, E. M., & Hickie, I. B. (2007) · BMC Psychiatry · doi:10.1186/1471-244x-7-32 · Cited by 146
Patient-reported functioning in major depressive disorder
IsHak, W. W., James, D. M., Mirocha, J., Youssef, H., Tobia, G., Pi, S., Collison, K. L., & Cohen, R. M. (2016) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622316639769 · Cited by 71
Lin, C.-H., Yen, Y.-C., Chen, M.-C., & Chen, C.-C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.039 · Cited by 57
Rytsälä, H. J., Melartin, T. K., Leskelä, U. S., Lestelä-Mielonen, P. S., Sokero, T. P., & Isometsä, E. T. (2006) · Journal of Nervous & Mental Disease · doi:10.1097/01.nmd.0000230394.21345.c4 · Cited by 50
Cited by
Air pollution exposure and depression: A comprehensive updated systematic review and meta-analysis
Borroni, E., Pesatori, A. C., Bollati, V., Buoli, M., & Carugno, M. (2022) · Environmental Pollution · doi:10.1016/j.envpol.2021.118245 · Cited by 269
Sumiyoshi, T., Watanabe, K., Noto, S., Sakamoto, S., Moriguchi, Y., Tan, K. H. X., Hammer-Helmich, L., & Fernandez, J. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.07.064 · Cited by 70
Self-citationWassink-Vossen, S., Collard, R. M., Wardenaar, K. J., Verhaak, P. F. M., Rhebergen, D., Naarding, P., & Voshaar, R. C. O. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2019.09.003 · Cited by 22
“Moreover, neurocognitive dysfunction has been associated with functional impairment over time among adults with MDD aged up to 65 years [37,38].”
BackgroundTomczyk, J., Nezlek, J. B., & Krejtz, I. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.878819 · Cited by 12
Knowlton, C. N., Kryvanos, A., Poole, M., Christopher, M., & Lafavor, T. (2019) · Clinical Case Studies · doi:10.1177/1534650119839156 · Cited by 11
Metadata
- Authors
- Hammer-Helmich, L., Haro, J. M., Jönsson, B., Tanguy Melac, A., Di Nicola, S., Chollet, J., Milea, D., Rive, B., & Saragoussi, D.
- Venue
- Neuropsychiatric Disease and Treatment
- Publisher
- Informa UK Limited
- Published
- 2018-01
- Volume
- Volume 14
- Pages
- 239-249
- ISSN
- 1176-6328 (ISSN-L)
- 1178-2021
- OpenAlex
- W2783590509
- Cited by
- 130
- References
- 24
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.